High dosage folic acid supplementation, oral cleft recurrence and fetal growth

International Journal of Environmental Research and Public Health

Volumn 10, Issue 2, 2013, Pages 590-605

  Wehby, George L ^a   Félix, Têmis Maria ^b   Goco, Norman ^c   Richieri Costa, Antonio ^d   Chakraborty, Hrishikesh ^e   Souza, Josiane ^f   Pereira, Rui ^g   Padovani, Carla ^h   Moretti Ferreira, Danilo ⁱ   Murray, Jeffrey C ^j  

^a UNIVERSITY OF IOWA   (United States)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c RTI INTERNATIONAL   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF SOUTH CAROLINA   (United States)

^f Centro de Atendimento Integral Ao Fissurado   (Brazil)

^g INSTITUTO OSWALDO CRUZ   (Brazil)

^h Department of Oral and Maxillofacial Surgery   (Brazil)

ⁱ SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^j UNIVERSITY OF IOWA   (United States)

more..

Author keywords

Birth defects; Brazil; Cleft lip; Cleft palate; Folic acid; Nutrition; Oral clefts; Pregnancy; Prevention; Vitamins

Indexed keywords

FOLIC ACID;

DRUG; HEALTH CARE; PREGNANCY; VITAMIN; WOMENS HEALTH;

ADOLESCENT; ADULT; ARTICLE; CELL LEVEL; CLEFT LIP PALATE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; FAMILY HISTORY; FEMALE; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HISTORIC RECURRENCE RISK; HUMAN; INFANT; LIVE BIRTH; LOW DRUG DOSE; MULTICENTER STUDY (TOPIC); NEWBORN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRENATAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RECURRENT DISEASE; UNSPECIFIED SIDE EFFECT;

EID: 84874907173     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph10020590     Document Type: Article

References (17)

1. Mossey, P.A.; Little, J.; Munger, R.G.; Dixon, M.J.; Shaw, W.C. Cleft lip and palate. Lancet 2009, 374, 1773-1785.
2. Wehby, G.L.; Nyarko, K.A.; Castilla, E.E.; Lopez-Camelo, J. Fetal health shocks and early inequalities in health capital accumulation. Health Economics 2013, doi: 10.1002/hec.2901
3. Wehby, G.L.; Almind-Pedersen, D.; Murray, J.; Christensen, K. The effects of oral clefts on hospital use throughout the lifespan. BMC Health Serv. Res. 2012, 12, doi: 10.1186/1472-6963-12-58
4. Wehby, G.L.; Ohsfeldt, R.L.; Murray, J.C. Health professionals' assessment of health-related quality of life values for oral clefting by age using a visual analogue scale method. Cleft Palate-Craniofac. J. 2006, 43, 383-391.
5. Wehby, G.; Cassell, C. The impact of orofacial clefts on quality of life and healthcare use and costs. Oral Dis. 2010, 16, 3-10.
6. Rahimov, F.; Marazita, M.L.; Visel, A.; Cooper, M.E.; Hitchler, M.J.; Rubini, M.; Domann, F.E.; Govil, M.; Christensen, K.; Bille, C. et al. Disruption of an AP-2[alpha] binding site in an IRF6 enhancer is associated with cleft lip. Nat. Genet. 2008, 40, 1341-1347.
7. Beaty, T.; Murray, J.; Marazita, M.; Munger, R.; Ruczinski, I.; Hetmanski, J.; Lang, K.; Wu, T.; Murray, T.; Fallin, M. et al. A genome wide association study of cleft lip with/without cleft palate using case-parent trios of European and Asian ancestry identifies MAFB and ABCA4 as novel candidate genes. Nat. Genet. 2010, 42, 525-529.
8. Dixon, M.J.; Marazita, M.L.; Beaty, T.H.; Murray, J.C. Cleft lip and palate: Understanding genetic and environmental influences. Nat. Rev. Genet. 2011, 12, 167-178.
9. Wehby, G.L.; Jugessur, A.; Moreno, L.M.; Murray, J.C.; Wilcox, A.; Lie, R.T. Genes as instruments for studying risk behavior effects: An application to maternal smoking and oraofacial clefts. Health Serv. Outcomes Res. Methodol. 2011, 11, 54-78.
10. Ludwig, K.U.; Mangold, E.; Herms, S.; Nowak, S.; Reutter, H.; Paul, A.; Becker, J.; Herberz, R.; AlChawa, T.; Nasser, E. et al. Genome-wide meta-analyses of nonsyndromic cleft lip with or without cleft palate identify six new risk loci. Nat. Genet. 2012, 44, 968-971.
11. Shi, M.; Wehby, G.L.; Murray, J.C. Review on genetic variants and maternal smoking in the etiology of oral clefts and other birth defects. Birth Defects Res. Pt. C Embryo Today 2008, 84, 16-29.
12. Wehby, G.L.; Murray, J.C. Folic acid and orofacial clefts: A review of the evidence. Oral Dis. 2010,16, 11-19.
13. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 1991, 338, 131-137.
14. Wehby, G.L.; Norman, G.; Danilo, M.-F.; Temis, F.; Antonio, R.-C.; Carla, P.; Fernanda, Q.; Vila Camilla, G.; Rui, P.; Steve, L. et al. Oral cleft prevention program (OCPP). BMC Pediatr. 2012, 12, doi: 10.1186/1471-2431-12-184.
15. Kondo, S.; Schutte, B.C.; Richardson, R.J.; Bjork, B.C.; Knight, A.S.; Watanabe, Y.; Howard, E.; de Lima, R.L.; Daack-Hirsch, S.; Sander, A. et al. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat. Genet. 2002, 32, 285-289.
16. Wehby, G.L.; Murray, J.C. The effects of prenatal use of folic acid and other dietary supplements on early child development. Matern. Child Health J. 2008, 12, 180-187.
17. Roth, C.; Magnus, P.; Schjolberg, S.; Stoltenberg, C.; Suren, P.; McKeague, I.W.; Smith, G.D.; Reichborn-Kjennerud, T.; Susser, E. Folic acid supplements in pregnancy and severe language delay in children. JAMA 2011, 306, 1566-1573.